Government of Norway
Also known as: City of Oslo, Norway | Department of Physical Performance, Norwegian School of Sports Science | Folkehelsa | Norwegian Council for Mental Health | Norwegian Defense Research Establishment | Norwegian Department of Health and Social Affairs | Norwegian Directorate of Health | Norwegian Institute of Public Health | Norwegian Labour and Welfare Administration | Norwegian ministry of Education and Research | Norwegian School of School of Sport Sciences | The Norwegian Directorate for Education and Training | The Norwegian Doping Control Laboratory | The Norwegian Institute of Food, Fisheries and Aquaculture research (NOFIMA) | The Norwegian National Advisory Unit on Ageing and Health | The Norwegian School of Sport Sciences | The Research Council of Norway | The Royal Norwegian Ministry of Health
Highest phase reached
Phase 4
First clinical trial
Dec 1, 1998Last known activity
Oct 24, 2024
Timeline
1880s
- Jan 1, 1884
Government of Norway— Founded
Drugs by trial phase (85 distinct, 53 trials)
Phase 4 (20 own, 0 via acquisition)
Phase 3 (20 own, 0 via acquisition)
Phase 2 (28 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Other trials (13 own, 0 via acquisition)
Indications
Studied for
- Anemia
- Arthritis
- Arthritis, Juvenile
- Attention Deficit Disorder with Hyperactivity
- Avitaminosis
- Back Pain
- Brain Diseases
- Cerebral Infarction
- Cerebral Palsy
- Colorectal Neoplasms
- Compulsive Personality Disorder
- Coronary Artery Disease
- Coronary Disease
- Dementia
- Diabetes Mellitus, Type 1
- Digestive System Diseases
- Diphtheria
- Encephalitis
- Encephalomyelitis
- Erythema
- Erythema Chronicum Migrans
- Fatigue
- Fatigue Syndrome, Chronic
- Gastrointestinal Diseases
- Glossitis, Benign Migratory
- Glucose Intolerance
- Glucose Metabolism Disorders
- Headache
- Hepatitis
- Hepatitis A
- Hepatitis E
- HIV Infections
- Hyperkinesis
- Hypersensitivity
- Hypertension
- Infarction
- Infections
- Influenza, Human
- Insulin Resistance
- Ischemia
- Liver Neoplasms
- Low Back Pain
- Lyme Disease
- Malaria
- Meningitis
- Meningitis, Meningococcal
- Meningococcal Infections
- Metabolic Diseases
- Multiple Myeloma
- Musculoskeletal Pain
- Myalgia
- Myocardial Infarction
- Myocardial Ischemia
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Plasma Cell
- Neoplasms, Second Primary
- Obsessive-Compulsive Disorder
- Opioid-Related Disorders
- Paralysis
- Periodontal Diseases
- Pneumonia
- Poliomyelitis
- Prostatic Neoplasms
- Psychomotor Agitation
- Respiratory Tract Infections
- Stroke
- Syndrome
- Tetanus
- Tetany
- Whooping Cough
Recent trials (50)
- NCT06653634CollaboratorPhase 4Oct 24, 2024
- NCT05631730CollaboratorPhase 3Dec 31, 2022
- NCT05352191CollaboratorPhase 4Sep 1, 2022
- NCT05210205CollaboratorN/AMar 13, 2022
- NCT04662866CollaboratorPhase 2Dec 10, 2020
- NCT04614311CollaboratorPhase 4Dec 1, 2020
- NCT04609423CollaboratorPhase 4Nov 10, 2020
- NCT04571866CollaboratorN/AOct 20, 2020
- NCT03691987CollaboratorPhase 2Nov 1, 2018
- NCT03446534CollaboratorPhase 4Mar 7, 2018
- NCT03326791CollaboratorPhase 2Dec 15, 2017
- NCT03334136CollaboratorN/ANov 24, 2017
- NCT03181360CollaboratorPhase 3Jun 12, 2017
- NCT03103074CollaboratorN/AMay 24, 2017
- NCT03538821CollaboratorN/AJan 31, 2017
Details
- Founded
- Oslo, NO Jan 1, 1884
- Last known activity
- Oct 24, 2024